Bengaluru-based Fibroheal Woundcare, a pioneering Indian startup in silk protein-based wound management, has raised Rs 6.3 crore in funding from promoters and a new group of investors, including prominent surgeons, medical professionals, and bankers. Additionally, the company has received a commitment of Rs 10 crore from existing and new investors for future growth.
This funding will enable Fibroheal to:
1. Scale Market Reach: Expand its go-to-market strategies.
2. Strengthen Workforce: Recruit new talent to drive growth.
3. Innovate Products: Invest in developing a robust pipeline of medical devices.
4. Leverage Biomaterials: Enhance the economic potential of silk and other biomaterials.
As the first Indian company to commercialize silk protein-based medical devices, Fibroheal is poised to revolutionize wound care and make a significant impact on the healthcare industry.
Disclaimer
Posts in the Notebook are written by individual members and reflect personal insights or opinions. Please verify any information independently. If you have any concerns, notify the admin immediately so we can take action before any legal steps are taken.
